Clin Colon Rectal Surg 2020; 33(05): 258-267
DOI: 10.1055/s-0040-1713743
Review Article

Staging of Locally Advanced Rectal Cancer Beyond TME

Deborah S. Keller
1   Division of Colorectal Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina
› Author Affiliations

Abstract

The management of rectal cancer is complex and continually evolving. With advancements in technology and the use of multidisciplinary teams to guide the treatment decision making, staging, oncologic, and functional outcomes are improving, and the management is moving toward personalized treatment strategies to optimize each individual patient's outcomes. Key in this evolution is imaging. Magnetic resonance imaging (MRI) has emerged as the dominant method of pelvic imaging in rectal cancer, and use of MRI for staging is best practice in multiple international guidelines. MRI allows a noninvasive assessment of the tumor site, relationship to surrounding structures, and provides highly accurate rectal cancer staging, which is necessary for determining the appropriate treatment strategy. However, the applications of MRI extend far beyond pretreatment staging. MRI can be used to predict outcomes in locally advanced rectal cancer and guide the surgical or nonsurgical plan, serving as a predictive and prognostic biomarker. With continued MRI hardware improvement and new sequence development, MRI may offer new perspectives in the assessment of treatment response and new innovations that could provide better insight into the staging, restaging, and outcomes with rectal cancer.



Publication History

Article published online:
30 June 2020

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 
  • References

  • 1 Heald RJ. The ‘Holy Plane’ of rectal surgery. J R Soc Med 1988; 81 (09) 503-508
  • 2 Quirke P, Steele R, Monson J. , et al; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. (9666): Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009; 373: 821-828
  • 3 Heald RJ, Santiago I, Pares O, Carvalho C, Figueiredo N. The perfect total mesorectal excision obviates the need for anything else in the management of most rectal cancers. Clin Colon Rectal Surg 2017; 30 (05) 324-332
  • 4 Taylor FG, Quirke P, Heald RJ. , et al; MERCURY Study Group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 2011; 253 (04) 711-719
  • 5 Ngan SY, Burmeister B, Fisher RJ. , et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol 2012; 30 (31) 3827-3833
  • 6 Park IJ, You YN, Agarwal A. , et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 2012; 30 (15) 1770-1776
  • 7 Fietkau R, Barten M, Klautke G. , et al. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 2006; 49 (09) 1284-1292
  • 8 Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a “wait and see” policy justified?. Dis Colon Rectum 2008; 51 (01) 10-19 , discussion 19–20
  • 9 Amin MB, Greene FL, Edge SB. , et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67: 93-99
  • 10 Brown G, Richards CJ, Newcombe RG. , et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999; 211 (01) 215-222
  • 11 Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90 (03) 355-364
  • 12 Patel UB, Blomqvist LK, Taylor F. , et al. MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience. AJR Am J Roentgenol 2012; 199 (04) W486-95
  • 13 Weiser MR, Quah HM, Shia J. , et al. Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 2009; 249 (02) 236-242
  • 14 Kao PS, Chang SC, Wang LW. , et al. The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol 2010; 102 (07) 771-777
  • 15 Beets-Tan RG. MRI in rectal cancer: the T stage and circumferential resection margin. Colorectal Dis 2003; 5 (05) 392-395
  • 16 Brown G, Daniels IR. Preoperative staging of rectal cancer: the MERCURY research project. Recent Results Cancer Res 2005; 165: 58-74
  • 17 Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”?. Radiology 2013; 268 (02) 330-344
  • 18 Beets-Tan RG, Beets GL, Vliegen RF. , et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357 (9255): 497-504
  • 19 Rullier A, Laurent C, Capdepont M. , et al. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival. Am J Surg Pathol 2008; 32 (01) 45-50
  • 20 McDonald JR, Renehan AG, O'Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg 2012; 4 (01) 9-19
  • 21 Brown G, Richards CJ, Bourne MW. , et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227 (02) 371-377
  • 22 Taylor FG, Quirke P, Heald RJ. , et al; Magnetic Resonance Imaging in Rectal Cancer European Equivalence Study Study Group. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol 2014; 32 (01) 34-43
  • 23 Shihab OC, Taylor F, Bees N. , et al; MERCURY Study Group. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg 2011; 98 (12) 1798-1804
  • 24 Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93 (10) 1215-1223
  • 25 Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology 2004; 232 (03) 773-783
  • 26 Benson III AB, Venook AP, Bekaii-Saab T. , et al. Rectal cancer, version 2.2015. J Natl Compr Canc Netw 2015; 13 (06) 719-728 , quiz 728
  • 27 Chand M, Evans J, Swift RI. , et al. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg 2015; 261 (03) 473-479
  • 28 Chand M, Bhangu A, Wotherspoon A. , et al. EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. Ann Oncol 2014; 25 (04) 858-863
  • 29 Shihab OC, Quirke P, Heald RJ, Moran BJ, Brown G. Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 2010; 97 (09) 1431-1436
  • 30 Habr-Gama A, Perez RO, Proscurshim I. , et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10 (10) 1319-1328 , discussion 1328–1329
  • 31 Balyasnikova S, Haboubi N, Moran B, Brown G. Histopathological and radiological reporting in rectal cancer: concepts and controversies, facts and fantasies. Tech Coloproctol 2017; 21 (01) 15-23
  • 32 MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006; 333 (7572): 779
  • 33 MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007; 243 (01) 132-139
  • 34 Smith NJ, Shihab O, Arnaout A, Swift RI, Brown G. MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 2008; 191 (05) 1517-1522
  • 35 Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95 (02) 229-236
  • 36 Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001; 16 (05) 298-304
  • 37 Merkel S, Mansmann U, Papadopoulos T, Wittekind C, Hohenberger W, Hermanek P. The prognostic inhomogeneity of colorectal carcinomas stage III: a proposal for subdivision of stage III. Cancer 2001; 92 (11) 2754-2759
  • 38 Pedersen BG, Moran B, Brown G, Blomqvist L, Fenger-Grøn M, Laurberg S. Reproducibility of depth of extramural tumor spread and distance to circumferential resection margin at rectal MRI: enhancement of clinical guidelines for neoadjuvant therapy. AJR Am J Roentgenol 2011; 197 (06) 1360-1366
  • 39 Wibe A, Rendedal PR, Svensson E. , et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89 (03) 327-334
  • 40 Glynne-Jones R, Mawdsley S, Novell JR. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Colorectal Dis 2006; 8 (09) 800-807
  • 41 Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D. ; Royal Marsden Hospital, Colorectal Cancer Network. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. Br J Cancer 2006; 94 (03) 351-357
  • 42 Marijnen CA, van de Velde CJ, Putter H. , et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 2005; 23 (09) 1847-1858
  • 43 Martling A, Holm T, Bremmer S, Lindholm J, Cedermark B, Blomqvist L. Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer. Br J Surg 2003; 90 (11) 1422-1428
  • 44 Adam IJ, Mohamdee MO, Martin IG. , et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344 (8924): 707-711
  • 45 Battersby NJ, How P, Moran B. , et al; MERCURY II Study Group. Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg 2016; 263 (04) 751-760
  • 46 Patel UB, Taylor F, Blomqvist L. , et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011; 29 (28) 3753-3760
  • 47 Chand M, Swift RI, Tekkis PP, Chau I, Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer 2014; 110 (01) 19-25
  • 48 Courtney ED, West NJ, Kaur C. , et al. Extramural vascular invasion is an adverse prognostic indicator of survival in patients with colorectal cancer. Colorectal Dis 2009; 11 (02) 150-156
  • 49 Sun Y, Li J, Shen L, Wang X, Tong T, Gu Y. Predictive value of MRI-detected extramural vascular invasion in stage T3 rectal cancer patients before neoadjuvant chemoradiation. Diagn Interv Radiol 2018; 24 (03) 128-134
  • 50 Patel UB, Brown G, Machado I. , et al. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. Ann Oncol 2017; 28 (02) 344-353
  • 51 Chand M, Siddiqui MR, Swift I, Brown G. Systematic review of prognostic importance of extramural venous invasion in rectal cancer. World J Gastroenterol 2016; 22 (04) 1721-1726
  • 52 Chand M, Rasheed S, Heald R. , et al. Adjuvant chemotherapy may improve disease-free survival in patients with mrEMVI-positive rectal cancer following chemoradiation. Colorectal Dis 2017; 19: 537-543
  • 53 Siddiqui MRS, Simillis C, Hunter C. , et al. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer 2017; 116 (12) 1513-1519
  • 54 Beets-Tan RGH, Lambregts DMJ, Maas M. , et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018; 28 (04) 1465-1475
  • 55 Adamina M, Buchs NC, Penna M, Hompes R. ; St.Gallen Colorectal Consensus Expert Group. St.Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc 2018; 32 (03) 1091-1103
  • 56 Georgiou PA, Tekkis PP, Constantinides VA. , et al. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer 2013; 49 (01) 72-81
  • 57 Georgiou PA, Tekkis PP, Constantinides VA. , et al. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal pelvic cancer. J Clin Oncol 2013; 49: 72-81
  • 58 Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Ann Surg 2014; 259 (02) 315-322
  • 59 Brown WE, Koh CE, Badgery-Parker T, Solomon MJ. Validation of MRI and surgical decision making to predict a complete resection in pelvic exenteration for recurrent rectal cancer. Dis Colon Rectum 2017; 60 (02) 144-151
  • 60 Eisenhauer EA, Therasse P, Bogaerts J. , et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45 (02) 228-247
  • 61 Marijnen CA, Glimelius B. The role of radiotherapy in rectal cancer. Eur J Cancer 2002; 38 (07) 943-952
  • 62 Påhlman L, Hohenberger W, Günther K, Fietkau R, Metzger U. Is radiochemotherapy necessary in the treatment of rectal cancer?. Eur J Cancer 1998; 34 (04) 438-448
  • 63 Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12 (01) 19-23
  • 64 Wheeler JM, Warren BF, Mortensen NJ. , et al. Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum 2002; 45 (08) 1051-1056
  • 65 Vecchio FM, Valentini V, Minsky BD. , et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62 (03) 752-760
  • 66 Kim SH, Chang HJ, Kim DY. , et al. What is the ideal tumor regression grading system in rectal cancer patients after preoperative chemoradiotherapy?. Cancer Res Treat 2016; 48 (03) 998-1009
  • 67 Mandard AM, Dalibard F, Mandard JC. , et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73 (11) 2680-2686
  • 68 Patel UB, Brown G, Rutten H. , et al. Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 2012; 19 (09) 2842-2852
  • 69 Siddiqui MR, Bhoday J, Battersby NJ. , et al. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales. World J Gastroenterol 2016; 22 (37) 8414-8434
  • 70 MacGregor TP, Maughan TS, Sharma RA. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now. J Clin Pathol 2012; 65 (10) 867-871
  • 71 Sclafani F, Brown G, Cunningham D. , et al. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer 2017; 117 (10) 1478-1485
  • 72 Schneider DA, Akhurst TJ, Ngan SY. , et al. Relative value of restaging MRI, CT, and FDG-PET scan after preoperative chemoradiation for rectal cancer. Dis Colon Rectum 2016; 59 (03) 179-186
  • 73 van den Broek JJ, van der Wolf FS, Lahaye MJ. , et al. Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation. Dis Colon Rectum 2017; 60 (03) 274-283
  • 74 Moreno CC, Sullivan PS, Mittal PK. MRI evaluation of rectal cancer: staging and restaging. Curr Probl Diagn Radiol 2017; 46: 234-241
  • 75 Pham TT, Liney GP, Wong K, Barton MB. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer. Br J Radiol 2017; 90 (1072): 20151078
  • 76 Barbaro B, Vitale R, Leccisotti L. , et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 2010; 30 (03) 699-716
  • 77 Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis Colon Rectum 2005; 48 (04) 722-728
  • 78 van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 2013; 269 (01) 101-112
  • 79 Zhao RS, Wang H, Zhou ZY, Zhou Q, Mulholland MW. Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis. Dis Colon Rectum 2014; 57 (03) 388-395
  • 80 Beets-Tan RG, Beets GL. MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer. Nat Rev Gastroenterol Hepatol 2014; 11 (08) 480-488
  • 81 Lambregts DM, Vandecaveye V, Barbaro B. , et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18 (08) 2224-2231
  • 82 Lambregts DMJ, Delli Pizzi A, Lahaye MJ. , et al. A pattern-based approach combining tumor morphology on MRI with distinct signal patterns on diffusion-weighted imaging to assess response of rectal tumors after chemoradiotherapy. Dis Colon Rectum 2018; 61 (03) 328-337
  • 83 Kim SH, Lee JM, Hong SH. , et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009; 253 (01) 116-125
  • 84 Sun YS, Zhang XP, Tang L. , et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254 (01) 170-178
  • 85 Zhu HB, Zhang XY, Zhou XH. , et al. Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: a prospective single-center study. J Magn Reson Imaging 2017; 46 (01) 175-183
  • 86 Lambrecht M, Vandecaveye V, De Keyzer F. , et al. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys 2012; 82 (02) 863-870
  • 87 Habr-Gama A, Gama-Rodrigues J, São Julião GP. , et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys 2014; 88 (04) 822-828
  • 88 Martens MH, Maas M, Heijnen LA. , et al. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst 2016; 108 (12) 108
  • 89 Koh DM, Blackledge M, Padhani AR. , et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 2012; 199 (02) 252-262
  • 90 Kluza E, Rozeboom ED, Maas M. , et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer. Eur Radiol 2013; 23 (01) 253-261
  • 91 Carbone SF, Pirtoli L, Ricci V. , et al. Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report. Radiol Med (Torino) 2012; 117 (07) 1112-1124
  • 92 De Cecco CN, Ganeshan B, Ciolina M. , et al. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. Invest Radiol 2015; 50 (04) 239-245
  • 93 Liu M, Lv H, Liu LH, Yang ZH, Jin EH, Wang ZC. Locally advanced rectal cancer: predicting non-responders to neoadjuvant chemoradiotherapy using apparent diffusion coefficient textures. Int J Colorectal Dis 2017; 32 (07) 1009-1012
  • 94 Sun Y, Xiao Q, Hu F. , et al. Diffusion kurtosis imaging in the characterisation of rectal cancer: utilizing the most repeatable region-of-interest strategy for diffusion parameters on a 3T scanner. Eur Radiol 2018; 28 (12) 5211-5220
  • 95 Lambregts DM, Rao SX, Sassen S. , et al. MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study. Ann Surg 2015; 262 (06) 1034-1039
  • 96 Kim S, Han K, Seo N. , et al. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2018; 28 (12) 5231-5240
  • 97 Trebeschi S, van Griethuysen JJM, Lambregts DMJ. , et al. Deep learning for fully-automated localization and segmentation of rectal cancer on multiparametric MR. Sci Rep 2017; 7 (01) 5301
  • 98 Ryan R, Gibbons D, Hyland JM et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005; 47: 141-146
  • 99 Wittekind C, Tannapfel A. [Regression grading of colorectal carcinoma after preoperative radiochemotherapy. An inventory]. Pathologe 2003; 24 (61) 65